OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Subscribe To Our Newsletter & Stay Updated
